Agilent Technologies Inc. is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Representatives: Steve Fischer, Christine Miller
At Biognosys, we believe that knowledge of the proteome holds the answers to understanding the phenotypic behaviour of complex biological systems. Biognosys is dedicated to developing superior proteomics solutions and offers these solutions to researchers as products and services. These solutions rely on mass spectrometry with parallel data-independent acquisition (DIA), which allow simultaneous quantification of thousands of proteins in a single experiment. Our next generation technology provides multiplexed protein quantification with high precision and depth.
Representatives: Claudia Escher, Oliver Rinner
Bruker provides innovative mass spectrometry systems for proteomics that overcome long-standing limitations in speed, sensitivity and robustness. We offer a complete range of proteomics solutions to enhance analytical depth and throughput and to minimize maintenance and downtime.
Representatives: Gary Kruppa, Pierre-Olivier Schmit
Bioinformatics Solutions Inc. (BSI) is a highly established company well-known for its PEAKS software and service platforms for proteomics discovery and therapeutic protein characterization by LC-MS. Its benchmark de novo sequencing capabilities, now advanced by deep learning, offers advanced solutions for proteomic and therapeutic protein discovery as provided through peptide/protein identification & quantification, peptide mapping, PTMs and sequence variants.
Representatives: Katherine Tran, Baozhen (Paul) Shan
Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the manufacturer of stable isotopes (e.g.,13C, D, 15N) and their compounds for an array of qualitative/quantitative research applications ranging from analytical chemistry to modern diagnostics. Proteomic products include peptide synthesis and protein expression starting materials, SILAC and SILAM reagents/kits, QC and quantitation kits, chemical tagging reagents, and enzymatic labeling reagents. CIL also offers an array of standards and mixes/kits for use in other MS ‘omics research (e.g., metabolomics, glycomics).
Representatives: Joel Louette, Andrew Percy
EVOSEP aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.
Representatives: Michael Andersen, Nicolai Bache
Fluidigm develops, manufactures, and markets research products for life science analytical and preparatory systems for use in mass cytometry, high-throughput genomics, and single cell genomics applications. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Representatives: Alexander Cherkassky, Andrew Quong
Newomics Inc. is a commercial stage biotechnology company in the San Francisco bay area. It is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. Its products include silicon-based multinozzle emitters (M3 emitters) and microfluidic LC-MS chips (MEA chips) that significantly increase the sensitivity and robustness of mass spectrometry.
Representatives: Daojing Wang
ProtiFi, LLC provides innovative solutions for omics analyses from sample preparation trough to data analysis and is a spin out of Cold Spring Harbor Laboratory. The S-Trap, our sample extraction, concentration and cleaning system, has revolutionized our ability to obtain MS ready samples in record time regardless of sample or skill level. Tryp-N, “N-terminal trypsin,” gives complementary data to increase sequence coverage and certainty of identification. Finally, Simplifi makes it easy and simple to go from huge omics datasets to meaning and understanding of biology.
Representatives: John Wilson, Darryl Pappin
SCIEX solutions for biomarker & omics research enable scientists to push the limits in discovery proteomics, targeted peptide quantitation, lipidomics, metabolomics, protein characterization, and tissue imaging.
Representatives: Arianna Jones, Tom Knapman
Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. KREX was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.
Representatives: Johan Poole-Johnson, Jonathan Blackburn
Thermo Scientific is the leading source of innovative, comprehensive workflow solutions to address the most challenging aspects of proteomics research.
Representatives: Aran Paulus, Julian Saba
PeakInvestigator® post-MS signal-processing software differentiates peak signals from noise with statistical confidence intervals, and deconvolves overlapped peaks with 5-6x higher resolution, revealing critical hidden information. PeakInvestigator operates on raw profile MS data for all sample types, from ion trap, TOF, Orbitrap and FTICR mass analyzers. PeptideDetective® software (alpha), outperforms current market leaders in de novo peptide identifications.
Representatives: Jeff Peterson, Mark Duncan
From biomarker discovery and translational research through to clinical diagnostic solutions, at Waters, we strive to improve human health by partnering with the biomedical community to help make breakthrough scientific discoveries and translate them into healthcare solutions.
Representatives: David Heywood, Roy Martin